Elemer Piros Analyst PerformanceAnalyst at Loop CapitalElemer Piros is a stock analyst at Loop Capital focused in the medical sector, covering 24 publicly traded companies. Over the past year, Elemer Piros has issued 1 stock ratings. While full access to Elemer Piros' proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Elemer Piros' coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings195 Last 10 YearsBuy Recommendations91.24% 177 Buy RatingsCompanies Covered24 Unique Companies Ratings Distribution194RatingsDistribution of strong buy, buy, hold, and sell ratings by Elemer Piros.RatingPercentageCount Strong Buy0.0%0 ratings Buy91.2%177 ratings Hold6.2%12 ratings Sell2.6%5 ratingsOut of 194 total stock ratings issued by Elemer Piros at Loop Capital, the majority (91.2%) have been Buy recommendations, followed by 6.2% Hold and 2.6% Sell.Best & Worst CallsBest Call0000.0%ARWRDec 2018Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%ABEOAug 2018Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ95.8% of companies on NASDAQ23 companiesNYSE4.2% of companies on NYSE1 companyElemer Piros, an analyst at Loop Capital, currently covers 24 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical23 companies95.8%Miscellaneous1 company4.2%Elemer Piros of Loop Capital specializes in stock coverage within the Medical sector, with additional focus on companies.Coverage IndustriesIndustryPercentageMED - BIOMED/GENE11 companies45.8%MED - DRUGS7 companies29.2%BIOTECHNOLOGY2 companies8.3%UNCLASSIFIED1 company4.2%MED INSTRUMENTS1 company4.2%MED PRODUCTS1 company4.2%PHARMACEUTICAL PREPARATIONS1 company4.2% Elemer Piros' Ratings History at Loop Capital Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsADILAdial Pharmaceuticals6/15/2026Set Price Target$2.98$6.00$0.0000.00% ROIBTAIBioXcel Therapeutics3/19/2025Initiated Coverage$2.50$65.00Buy$0.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenCitigroupMorgan StanleyRoyal Bank Of CanadaThe Goldman Sachs GroupDeutsche Bank AktiengesellschaftBMO Capital MarketsCanaccord Genuity GroupBerenberg BankCanadian Imperial Bank of CommerceBNP Paribas ExaneShore Capital GroupATB Cormark Capital MarketsTDNordea Equity Research Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
